BioPharma APAC

LifeScience Clinical & Diagnostic

Concord Medical Announces Changes in Management

Mr. Yaw Kong Yap has stepped down from his role as the chief financial officer and president of the Company due to reaching retirement age, effec...

October 03, 2022 | News

First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent

As Illuccix rolls out to positron emission tomography (PET) sites across the country, Mercy Radiology in Auckland became the first to administer ...

September 30, 2022 | News

Metabolon Expands Data Access Strategy to Include Health for Life in Singapore (HELIOS) Study

Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, ...

September 28, 2022 | News

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...

September 27, 2022 | News

Shandong Proton Center Celebrates Milestone in Delivering High-Quality Proton Treatment

Proton therapy can be used to treat many of the most common types of cancer. All radiotherapy, including proton and high energy X-rays (photon), destroys c...

September 26, 2022 | News

Menarini and SciClone to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumo...

September 21, 2022 | News

Australia approved New treatment for rare cancer cholangiocarcinoma

A NEW targeted therapy to treat a rare bile duct cancer called cholangiocarcinoma has been approved for use in Australia. PEMAZYRE® (pemigat...

September 16, 2022 | News

Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio

The award will fund the continued advancement of the company's proprietary PANDAA™ technology platform and its specific application to the univ...

September 13, 2022 | News

Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections

Respiratory tract infections are associated with high morbidity and mortality worldwide, and their symptoms may not point to a single diagnosis. In such ca...

September 07, 2022 | News

KOAG Receives FDA Clearance for Vascette® HP Hemostatic Pad for Vascular Closure

Vascette® is a unique, topical closure pad incorporating a proprietary, plant-derived hemostatic foam. The Vascette® patent-pending technology supp...

August 25, 2022 | News

Sonde Health Inks Multi-Year Partnership with Koye Pharmaceuticals

Sonde Health, a leading enterprise vocal biomarker company, has signed a multi-year agreement with Koye Pharmaceuticals, a specialty pharma organizati...

August 25, 2022 | News

3Brain AG and CSEM collaborate to launch Accura-3D microchip for the investigation of 3D cellular networks

Caption: 3D CMOS chip for connecting electroactive tissues and organoids to software.To download image, please click here. ...

August 24, 2022 | News

Menarini Group's Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA)

lacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line...

August 21, 2022 | News

BD, Accelerate Diagnostics Announce Global Commercial Collaboration

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Accelerate Diagnostics, Inc. (NASDAQ:...

August 15, 2022 | News

Stay Connected